Unraveling the Mystery: A Comprehensive Approach to Diagnosing and Managing Chronic Cough in Clinical Practice
OthersPage Navigation
Introduction
Chronic cough, defined as a cough lasting more than eight weeks, is a common yet challenging condition to manage in clinical practice. Despite its prevalence, the etiological factors and effective management strategies remain enigmatic.
Etiological Factors
Chronic cough is frequently associated with conditions such as asthma, gastroesophageal reflux disease (GERD), and postnasal drip syndrome (PNDS). However, it can also be a symptom of less common diseases such as lung cancer, tuberculosis, and sarcoidosis.
Diagnostic Approach
A comprehensive diagnostic approach should include a detailed patient history, physical examination, and appropriate investigations. The use of diagnostic tools such as chest X-rays, spirometry, and bronchoscopy can aid in identifying the underlying cause.
Management Strategies
Management should be tailored according to the identified cause. For instance, GERD-associated cough may respond to proton pump inhibitors, while PNDS may require antihistamines or corticosteroids. In refractory cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be necessary.
Conclusion
Unraveling the mystery of chronic cough requires a comprehensive, patient-centered approach. By understanding the potential etiological factors and employing appropriate diagnostic and management strategies, clinicians can effectively address this challenging condition.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge